A E2 alpha, Prostaglandin CEP of the European Pharmacopoeia monograph is often referred to as a E2 alpha, Prostaglandin Certificate of Suitability (COS). The purpose of a E2 alpha, Prostaglandin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of E2 alpha, Prostaglandin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of E2 alpha, Prostaglandin to their clients by showing that a E2 alpha, Prostaglandin CEP has been issued for it. The manufacturer submits a E2 alpha, Prostaglandin CEP (COS) as part of the market authorization procedure, and it takes on the role of a E2 alpha, Prostaglandin CEP holder for the record. Additionally, the data presented in the E2 alpha, Prostaglandin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the E2 alpha, Prostaglandin DMF.
A E2 alpha, Prostaglandin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. E2 alpha, Prostaglandin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of E2 alpha, Prostaglandin suppliers with CEP (COS) on PharmaCompass.